Dr. Michael R. Hamblin is one of the foremost researchers in the field of Low Level Light Therapy (LLLT) and Photodynamic Therapy. In his role as principle investigator at Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School, Dr. Hamblin studies the applications of photodynamic therapy to cancer, infections and heart disease, and the use of low-level light therapy for wound healing, hair regrowth, inflammatory disorders, and brain damage.
To date, Dr. Hamblin has authored or co-authored 86 peer-reviewed scientific research papers, filed over 12 U.S. patent applications, and given over 50 invited lectures in North America, Europe, and Asia.
In addition, Dr. Hamblin chairs an annual conference at SPIE Photonics West BiOS meeting in San Jose, CA entitled “Mechanisms for Low Level Light Therapy”. Dr. Hamblin obtained his Ph.D. from Notthingham Trent University in England in 1977. Specific Research Interests of Dr. Hamblin Include:
* Photodynamic inactivation of pathogens
* Antimicrobial PDT for localized infections
* PDT-induced anti-tumor immunity
* Macrophage-targeted PDT
* Detection and therapy of vulnerable atherosclerotic plaque
* Low level light therapy for healing and biostimulation
* Blue-light therapy for H. pylori infection
* Miscellaneous projects
Dr. Hamblin will assist Lexington in further researching the mechanisms of action behind the HairMax LaserComb and to develop specifications and parameters for further forays into the home use light therapy market.
|
